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Editorial on the Research Topic
Editorial: Innate Immunity in Normal Pregnancy
In pregnancy, successful implantation, placental development and fetal growth, as well as
maintenance of bothmaternal, and fetal health, requires balance of the immune response. Excessive
activation of the immune system increases risk of rejection of the fetus and adverse pregnancy
outcomes. In addition, disturbances in the immune system can lead to maternal or fetal infection.
Due to cross-talk, both innate, and adaptive immunitymust be properly regulated. Both our current
topic “Innate Immunity in Normal and Adverse Pregnancy” and the parallel topic “Adaptive
Immunity in Pregnancy” attracted 10–12 manuscripts. The articles in our topic included original
research and comprehensive reviews and fell into 3 general categories: role of complement system,
importance of innate immune cells, and an evaluation of innate immunity in infections in
pregnancy. Each category evaluated the innate response in orchestrating a normal pregnancy or
contributing to pathophysiology of adverse pregnancy outcomes (Figure 1). The timeliness of this
topic is highlighted by the clear contribution of innate immunity to the pathology of COVID-
19 infection and the potential impact on pregnancy outcomes (1, 2). This topic also synchronizes
with the recent call by the Surgeon General in the United States indicating “we can—and must—
do more for our moms” in reducing morbidity and mortality in pregnancy (https://www.hhs.gov/
sites/default/files/call-to-action-maternal-health.pdf).
THE COMPLEMENT SYSTEM IN NORMAL AND ADVERSE
PREGNANCY
The complement system is critical to healthy pregnancy due its central role in host defense.
Activation of complement proteins provide immediate defense against foreign pathogens through
opsonization, inflammation, and cell membrane attack. However, the role of complement in normal
pregnancy extends well-beyond host defense. Girardi et al. provide an excellent review on the
wide-ranging role of complement throughout pregnancy, including in normal pre-implantation,
implantation, placental development, cervical remodeling, and parturition. To complete these
normal pregnancy milestones successfully, homeostasis must be achieved by balancing regulation
and activation of the complement system. Yet, we remain a long way from fully understanding
how complement regulates even fundamental pregnancy processes, such as labor. Livson et al. shed
some light on this topic, through original data demonstrating laboring women at term have greater
C3 in cervicovaginal secretions, but a lower percentage of C3 activation, compared to non-laboring,
or non-pregnant women.
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Complement homeostasis is most critical at the maternal-
fetal interface, where excess complement activation may lead
to adverse pregnancy outcomes (3). Girardi et al. describe
how the complement system becomes dysregulated at various
stages leading to early pregnancy loss, placental insufficiency,
preeclampsia and preterm birth, with associated long-term
adverse effect to both mother and child. This association has
been most well-characterized in pregnant women with immune
complex disorders, such as systemic lupus erythematosus and
antiphospholipid antibody syndrome (4). Chighizola et al.
provide a current review describing the role of complement
in pregnancy-associated autoimmune disease, expanding our
understanding of the role of immune complexes and placental
complement deposition in mediating adverse outcomes. Finally,
Lokki et al. describe a case of pregnancy-associated atypical
hemolytic uremic syndrome, which occurred after delivery for
preeclampsia and HELLP syndrome. This case describes rapid
clinical improvement and resolution of renal failure following
complement (C5) blockade with eculizumab and emphasizes
the emergence of complement inhibition as a therapeutic
strategy for not only atypical hemolytic uremic syndrome,
but potentially other pregnancy disorders characterized by
complement dysregulation.
ROLE OF INNATE IMMUNE CELLS IN
PREGNANCY
The sentinel innate immune cells in decidua, placenta and fetus
include neutrophils, macrophages, dendritic cells, innate B1
cells and innate lymphoid cells (5) (ILCs including NK cells).
These innate immune cells protect both mother and fetus from
infection throughout pregnancy and are also instrumental in
orchestrating a normal pregnancy. Furthermore, these cells play
a critical role in educating the adaptive response to induce
tolerance. In general, the timeline of pregnancy is thought to
cycle through an inflammatory phenotype in implantation to a
protective anti-inflammatory state in maintenance of pregnancy,
and a return to inflammatory phenotype at labor (6). However,
Ono et al. present data in a mouse model indicating that
while macrophages are required for implantation, the effective
macrophages express an anti-inflammatory, M2-like phenotype.
Thus, our simplistic view of inflammation in pregnancy requires
modification. Similarly, dendritic cells are known to be essential
for successful embryo implantation (7), and Yasuda et al. probes
the phenotype of uterine dendritic cells between coitus and
implantation to better understand their role. Mendes et al.
reviews ILCs focusing on distinctions between peripheral and
decidual NK cells. In addition, they highlight a potential role
for other ILCs in establishing and maintaining a successful
pregnancy and in contributing to adverse pregnancy outcomes.
Much work is needed to fully understand the classification
and contribution of Group 1, 2, and 3 ILCs and NK cells to
pregnancy pathology.
During many pathophysiological conditions such as
preeclampsia, both innate immune cells and barrier cells
produce an exaggerated and inappropriate pro-inflammatory
microenvironment. Aneman et al. discusses the cells
contributing to the pro-inflammatory environment, including
M1 macrophages, gamma delta T cells, NK cells and B1a B cells.
Silva et al. demonstrates a contribution of decidual cells to the
proinflammatory microenvironment with increased activation
of NLRP3 inflammasome and subsequent IL-1β production
in preeclamptic pregnancies without fetal growth restriction
compared to normal pregnancies. Hypertensive pregnancy
disorders, such as preeclampsia, result in increased risk of
later-life cardiovascular disease for both the affected mother
and the infant born from the preeclamptic pregnancy (8). Silva’s
data suggests that the potential benefits of statin treatment in
pregnancy may be due to alterations in decidual cholesterol
and the NLRP3 inflammasome, reducing risk of subsequent
cardiovascular disease.
INNATE IMMUNITY AND INFECTION IN
PREGNANCY
The innate immune system changes throughout pregnancy
but these adaptations must not compromise the ability of the
immune system to protect mother and child from infection.
The innate immune response recognition of pathogen associated
molecular patterns that interact with molecules such as Toll
like receptors (TLRs) is an early line of defense for clearance
of microorganisms. In pregnancy, bacterial infection has been
associated with spontaneous preterm labor (9). However, the
contribution of viral infection to preterm labor remains unclear.
Rasheed et al. explore the concept of multi-pathogen induced
preterm labor, revealing a synergistic effect of bacterial and
viral TLR stimulation on a pro-inflammatory pro-labor response.
These data lend support to the idea that multiple hits of viral
and/or bacterial pathogens could increase the risk for preterm
labor. These studies call for more detailed analyses of multiple
pathogens both locally in the reproductive tract and systemically
and their association with spontaneous preterm birth.
The review of innate immunity and viral infection during
pregnancy by Cornish et al. provides an excellent overview
of how acute viral infections challenge the critical balance
between immune tolerance and defense against infection during
pregnancy. The serious public health challenge posed by SARS-
CoV2 infection and the concerns for upsetting a normal
pregnancy demonstrates the timeliness of the topic. The fact
that influenza and hepatitis E infection increase mortality of
pregnant women, makes COVID-19 a clear cause for concern.
Cornish et al. focuses on RNA viruses that may cause severe
disease in pregnancy. The authors emphasize the importance
of understanding the immune response during pregnancy and
consideration of pregnancy in the design of vaccine trials.
The review by Hoo et al. takes a slightly different view of
innate immunity and infection, focusing on the human decidual
placental interface during both bacterial and viral infections.
How do infections take hold in the presence of this significant
placental barrier? A review of the architecture and important
innate immune cells is nicely diagramed to highlight both cellular
and soluble immune defenses.
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FIGURE 1 | Regulation of the innate immune response influences pregnancy outcomes. When regulated, complement and the innate immune cells, including
macrophages, neutrophils, and innate lymphoid cells, control infection and promote a successful pregnancy. Excessive or dysregulated innate responses due to
uncontrolled infection, autoimmune disease, genetic predisposition, or other risk factors result in adverse pregnancy outcomes. Size depicts the magnitude of
infection and/or activation of the innate immune response. Created with biorender.com.
CONCLUSION
This research topic highlights the diversity of innate immune
processes crucial for a healthy pregnancy. More research
is needed to enhance understanding of interaction and
regulation of innate immunity during pregnancy and to
introduce novel therapeutic strategies to address the clinical
challenges posed by the complicated pregnancy. Thus, a healthy
pregnancy requires an innate cellular and humoral response for
proper development, but an inappropriate response results in
adverse events.
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